This is an awareness campaign for Teva Oncology. While it is considered the 10th largest oncology company in the US, awareness among key stakeholders was low. AbelsonTaylor sought to change that by developing a campaign emphasizing how Teva Oncology focuses on the patient. The awareness campaign was introduced at ASCO in May 2014. Qualitatively, the responses have been extremely positive.
Why This Work is Special:
Our creative team developed a campaign where emotion emanates from every image and every word. By taking common words in oncology – chemotherapy, apoptosis, metastasis, malignancy – and finding the “hidden meaning” within them, the campaign, “In a Word,” shows that cancer touches more than just the patient. The tagline, “We see so much more than just cancer,” reiterates Teva Oncology’s vision.
Brad Graetz, Creative Director; Tom Mateja, Assoc. Creative Director, Art; Dave Stratton, Senior Copywriter; Kevin Tran, Senior Art Director; Robert Williams, Assoc. Creative Director, Copy. Account Team: Andrea Kartley, Account Supervisor; Molly Korsch, Senior Account Supervisor; Claire Ogdon, Account Executive; Mike Perry, VP, Account Director
- Company Resources
Quality Assurance Best Practices in Digital Marketing
Featured White Paper
Quality Assurance Best Practices in Digital Marketing is the work of like-minded people – pharma, agencies, and QA professionals – focused on reducing costly QA problems than can surface when developing digital products. AbelsonTaylor has been helping clients improve the quality outcomes of their digital products for more than 15 years. The White Paper is an example of our established approach to digital QA.
AbelsonTaylor delivered a perfect pitch of a different kind last night when the agency's in-house ensemble, Hard to Swallow, won Pharmapalooza 6, the industry's annual battle of the bands contest.
From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.
Consumer work that creatively breaks the healthcare barriers and, most importantly, drives customers to act
The Association of Medical Media (AMM) will honor the top journal ads in 13 categories at its annual Doctors' Choice awards luncheon, September 24, at The Palace Hotel in New York City.
Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.